A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza

Clinical trial NCT00705406 · COMPLETED

Trial details

NCT number: NCT00705406
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute, Uncomplicated Human Influenza

Start date: 2008-07-01
Primary completion: 2009-04-01
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.